Tecan
Tecan Group Ltd, commonly referred to as Tecan, is a leading global provider of laboratory instruments and solutions, headquartered in Switzerland (CH). Founded in 1980, Tecan has established itself as a key player in the life sciences and diagnostics industries, with a strong presence in Europe, North America, and Asia. The company specialises in the development and manufacturing of automated laboratory systems, including liquid handling, microplate readers, and assay development tools. Tecan's innovative products are designed to enhance laboratory efficiency and accuracy, making them indispensable in research and clinical settings. With a commitment to quality and innovation, Tecan has achieved significant milestones, including numerous awards for its cutting-edge technologies. The company is recognised for its strong market position, serving a diverse clientele that includes pharmaceutical, biotechnology, and academic institutions worldwide.
DitchCarbon Score
How does Tecan's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tecan's score of 98 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tecan's reported carbon emissions
In 2024, Tecan Group Ltd. reported total greenhouse gas emissions of approximately 442,308,000 kg CO2e. This includes 2,010,000 kg CO2e from Scope 1 emissions, primarily from mobile and stationary combustion, and 1,031,000 kg CO2e from Scope 2 emissions, which are associated with purchased electricity and heat. The majority of their emissions, about 439,268,000 kg CO2e, fall under Scope 3, encompassing areas such as the use of sold products and business travel. Tecan has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Additionally, they plan to achieve a 90% reduction in total emissions across all scopes by 2050. Tecan is also committed to sourcing 100% renewable electricity by 2025, increasing from 34% in 2022. These targets have been validated by the Science Based Targets initiative, aligning with the goal of limiting global warming to 1.5°C. Tecan's proactive approach reflects its dedication to sustainability and climate responsibility, positioning the company as a leader in the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 613,690 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 696,460 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 2,770,130 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tecan is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
